The Emerging Role of Combination Angiogenesis Inhibitors and Immune Checkpoint Inhibitors in the Treatment of Metastatic Renal Cell Cancer
Amanda Nizam(Cleveland Clinic), Jeanny B. Aragon‐Ching(Inova Fairfax Hospital), Brinda Gupta(Georgetown University), Logan Rhea(Inova Fairfax Hospital)
Cited by 1
Related Papers
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
American Cancer Society prostate cancer survivorship care guidelines
|CA A Cancer Journal for Clinicians|2014|402
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
|Journal of Clinical Oncology|2023|210
Prospective Assessment of Pediatrician-Diagnosed Food Protein–Induced Allergic Proctocolitis by Gross or Occult Blood
|The Journal of Allergy and Clinical Immunology In Practice|2020|101
Improving the Radiosensitivity of Radioresistant and Hypoxic Glioblastoma
|Future Oncology|2010|60